Results 1 to 10 of about 61,568 (292)
Nailfold capillaroscopy in myositis: A case series [PDF]
SAGE Open Medical Case ReportsNailfold capillaroscopy is well established in systemic sclerosis; however, abnormalities (scleroderma or scleroderma-like patterns) are identified in other connective tissue diseases, such as myositis, even in the absence of Raynaud’s phenomenon ...
Thaisa Cotton +4 more
doaj +2 more sources
The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
Arthritis Research & Therapy, 2020 Background A myositis-specific autoantibody can now be identified in the majority of patients with myositis. They identify homogeneous patient subgroups and are key tools in developing a personalized approach to disease management.
Sarah L. Tansley +8 more
doaj +2 more sources
Focal Myositis Localised in Gastrocnemius Muscle: is it Different from Isolated Gastrocnemius Myositis? A Case Report [PDF]
Malaysian Orthopaedic Journal, 2021 Focal myositis is a rare disease defined by an isolated inflammatory pseudotumour usually restricted to one skeletal muscle. Approximately, 250 cases of focal myositis have been described in the literature, and two recent large cohorts have been used to ...
Son IS, Kim JS, Yoo SJ, Kang MS, Hyun CL
doaj +1 more source
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
Nature Reviews Rheumatology, 2023 Juvenile idiopathic inflammatory myopathies (JIIMs) can differ from adult-onset myopathies in terms of the pathogenesis, autoantibody profile, disease phenotype and treatment response, but these differences need to be further defined.
C. Papadopoulou +4 more
semanticscholar +1 more source
Frontiers in Immunology, 2022 Immune-mediated necrotizing myopathy (IMNM) is characterized by manifestation of myonecrosis and regeneration of muscle fibers; however, the underlying pathogenesis remains unclear. This study aimed to investigate the role and mechanism of miR-18a-3p and
Lifang Ye +8 more
doaj +1 more source
COVID-19 and Myositis: What We Know So Far
Current Rheumatology Reports, 2021 Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges ...
Ahmad Saud +3 more
semanticscholar +1 more source
Frontiers in Immunology, 2022 BackgroundInterstitial lung disease (ILD) is frequently observed in anti-melanoma differentiation-associated protein 5 (MDA5) antibody positive dermatomyositis (DM) and anti-synthetase syndrome (ASS), where they often develop a rapidly progressive ILD ...
Yu Zuo +8 more
doaj +1 more source
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
Annals of the Rheumatic Diseases, 2022 Objectives Inflammatory myopathy or myositis is a heterogeneous family of immune-mediated diseases including dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotising myopathy (IMNM) and inclusion body myositis (IBM).
I. Pinal‐Fernandez +29 more
semanticscholar +1 more source
Frontiers in Immunology, 2022 ObjectiveTo evaluate adrenomedullin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of patients with dermatomyositis (DM) as well as their correlation with the severity of interstitial lung disease (ILD).MethodsA total of 41 DM patients and
Lifang Ye +13 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: Immune checkpoint inhibitor (ICI)-related myositis with myocarditis is a rare but potentially fatal immune-related adverse event. However, its clinical features, response to immunosuppressive treatment, and prognosis remain poorly understood.
Yuki Nakagomi +9 more
semanticscholar +1 more source